Sunday, October 10, 2004 - 11:20 AM
5848

Bone Marrow Stem Cells and Resorbable Collagen Matrix Heals Alveolar Cleft Defects With Reduced Morbidity

Catherine O'Hara, BA, Manisha Sisodia, Mike Gimbel, MD, Libby Wilson, MD, and James P. Bradley, MD.

Introduction: Iliac crest cortical bone is an effective technique for correction of cleft alveolar defects but patients have significant hip discomfort post-harvest. Previously in our laboratory, critical-sized rabbit femoral defects were histologically healed with bone marrow stem cells seeded on collagen. To investigate the efficacy of a similar technique in alveolar cleft defects, volumetric bone healing of clefts treated with bone-marrow stem cells and collagen was compared those clefts treated with traditional iliac bone. Methods: Patients with unilateral alveolar cleft defects were prepared orthodontically and randomly divided into 2 equal treatment groups: 1) iliac crest bone graft or 2) bone marrow aspirate seeded on collagen (n=18). Preoperative and follow-up (mean=8 months) evaluations, intraoral photographs, NewTom orthognathic xrays (panorex, periapical films and 3-D CT scans) were performed. Wound and bone healing, tooth eruption and volumetric closure of the alveolar defect were recorded. Results: Patients ages ranged from 6 to 11 years (mean=7.9 years). Preoperative volume defects ranged from 5.1ccs to 10.3ccs and was 6.8ccs in Group 1 (iliac bone) and 7.1cc in Group 2 (stem cells). Postoperatively, 2 group 1 patients had bone exposure and 0 group 2 patients had exposure. In follow-up, alveolar defects were filled with new bone as follows-Group 1 (iliac bone) >90%=5 patients, 50-90%=2 patients, <50%=2 patients and Group 2 (stem cells): >90%=6 patients, 50-90%=3 patients, <50%=0 patients. Tooth eruption was as follow: Group 1=5 of 9 patients and Group 2=4 of 9 patients. Group 2 patients had less hip pain by survey and select Group 2 patients (3/9) had outpatient procedures. Conclusions: From these data we concluded that bone marrow derived stems cells seeded appropriately on a collagen matrix will heal alveolar cleft defects. To decrease the donor site morbidity further, an ongoing study involves processed lipoaspirate (PLA) (stem) cells (from liposuction) and BMP-2 on a similar collagen matrix in alveolar cleft defects.
View Synopsis (.doc format, 0 kb)